Food Business Network A new study published by the German Institute of Human Nutrition shows that palatinose, a hypoglycemic carbohydrate, is more effective in reducing insulin secretion and lowering blood sugar variability. This result helps to promote the formation of palatinose as a viable alternative to sugar, and is also a good news for patients with type 2 diabetes (T2D). As we all know, excessive sugar intake increases insulin tolerance and T2D risk. Metabolic benefits and low sugar index mean that it is also suitable for meal replacement, hypoglycemic powder soups, liquid and solid supplements in the nutritional field.
In this randomized, double-blind, crossover study, participants consisted of 2 women and 8 male T2D patients with an average age of 61 years and a BMI of 32.1. After a full night of fasting, participants ingested 300 ml of non-distilled or sucrose water containing 50 g of palatinose. Due to its slow digestive properties, palatinose acts through K-cells located at the upper end of the intestine and reaches the lower end of the gut, GLP-1, which in turn produces L-cells. These hormones play an important role in blood glucose regulation, insulin release, and the development of insulin resistance and type 2 diabetes.
The results of the study showed that in the T2D population, Paladin sugar reduced insulin secretion by 55% and blood glucose fluctuation by 20%. In addition, the release of palatinose by hormonal inhibitory peptide (GIP) and glucagon-like peptide-1 (GIP-1) compared to sucrose suggests that its molecular bond and relatively slow release properties play a role A better character. GIP release was reduced by 40% and GIP-1 secretion was significantly increased, 6.3 times higher than sucrose. The researchers said that because glucose and fructose can be completely reabsorbed, the difference in gut hormone response can explain the superior metabolic performance that occurs after palatinose intake.
Previous studies have shown that palatinose is completely absorbed and digested in the small intestine compared to sucrose, and blood sugar dynamics are improved to prevent fatty liver. In a rat model trial, the researchers found that palatinose reduced postprandial GIP and insulin release.
According to Beneo's leaders, these results provide more evidence that the metabolites of palatinose, when mixed with other sugars, provide a satisfying taste. According to national regulations, palatinose can also be combined with high-sweet sweeteners. For example, mixing palatinose with a sweetener such as stevia in a 1:1 ratio provides a good sweetness without changing the capacity and texture. A 4 kJ/g dose of palatinose can replace sugar and other high blood sugar carbohydrates such as maltose. In addition, it is in powder form to be the second candidate component of the exercise supplement.
Tetanus Shot,Tetanus Vaccine,Hepatitis B Injection,Hep B Vaccine
FOSHAN PHARMA CO., LTD. , https://www.fs-pharma.com